DOCSLIB.ORG

Internal Medicine In-Review Study Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Internal Medicine In-Review Study Guide INTERNAL MEDICINE IN-REVIEW STUDY GUIDE Companion to the Online Study System InReviewIM.com Senior Editor Norman H. Ertel, MD Associate Editors James M. Horowitz, MD Miguel A. Paniagua, MD, FACP Available through support from the makers of Powered by © 2013 Educational Testing & Assessment Systems. All Rights Reserved. This document contains proprietary information, images, and marks of Educational Testing & Assessment Systems. No reproduction or use of any portion of the contents of these materials may be made without the express written consent of Educational Testing & Assessment Systems. If you feel you have obtained this illegally, please contact Educational Testing & Assessment Systems immediately. The questions and answers, statements or opinions contained in this Study Guide or Web Site have not been approved by McNeil Consumer Healthcare Division of McNEIL-PPC, Inc., the makers of TYLENOL®. McNeil will not be held responsible for any questions and answers, statements or opinions, contained in the Study Guide, Web Site, or any supplementary materials. Any questions about the content of Internal Medicine In-Review should be directed to Educational Testing and Assessment Systems, Inc. which controls the content and owns all copyrights in the materials. The developments in medicine are always changing, from clinical experiences, new research, and changes in treatment and drug therapy. The Internal Medicine In-Review team use reasonable efforts to include information that is complete and within accepted standards at the time of publication. However, the faculty, authors, publisher, nor any other party who has been involved in the preparation of Internal Medicine In-Review make representations, warranties, or assurances as to the accuracy, currency, or completeness of the information provided. Users of Internal Medicine In-Review are encouraged to confirm the information contained with other sources. The publishers of this guide shall not be liable for any damages or injury resulting from your access to this guide, or from your reliance on any information provided in this guide. This guide is intended for U.S. physicians only and is not in any means intended for use by the general public. ISBN 978-0-9858025-1-6 © 2012 Published by Educational Testing & Assessment Systems, a product of SanovaWorks Edited by Norman H. Ertel, MD All rights reserved. No part of this book may be reproduced in any form or by any means, without permission in writing from the publisher. Printed in the United States of America © 2013 Educational Testing & Assessment Systems. All Rights Reserved. This document contains proprietary information, images, and marks of Educational Testing & Assessment Systems. No reproduction or use of any portion of the contents of these materials may be made without the express written consent of Educational Testing & Assessment Systems. If you feel you have obtained this illegally, please contact Educational Testing & Assessment Systems immediately. INTERNAL MEDICINE IN-REVIEW STUDY GUIDE MODULE 1 © 2013 Educational Testing & Assessment Systems. All Rights Reserved. This document contains proprietary information, images, and marks of Educational Testing & Assessment Systems. No reproduction or use of any portion of the contents of these materials may be made without the express written consent of Educational Testing & Assessment Systems. If you feel you have obtained this illegally, please contact Educational Testing & Assessment Systems immediately. 1 General Internal Medicine Fred Buckhold, MD Contents 1.1 ROUTINE CARE OF THE HEALTHY PATIENT . 2 1.2 GERIATRIC MEDICINE . .4 1.3 PERI-OPERATIVE MEDICINE . 5 1.4 PATIENT SAFETY . 6. 1.5 PROFESSIONALISM AND ETHICS . .6 1.6 PALLIATIVE CARE . 7 1.7 COMMON SYMPTOMS . 8 1.8 MEN'S HEALTH . 13 GENERAL INTERNAL MEDICINE 1 © 2013 Educational Testing & Assessment Systems. All Rights Reserved. This document contains proprietary information, images, and marks of Educational Testing & Assessment Systems. No reproduction or use of any portion of the contents of these materials may be made without the express written consent of Educational Testing & Assessment Systems. If you feel you have obtained this illegally, please contact Educational Testing & Assessment Systems immediately. 1.1 ROUTINE CARE OF THE HEALTHY PATIENT Screening Assessing patients for risk or presence of asymptomatic disease and identifying lifestyle choices that have health consequences. • Often based on prevalence of diseases • The United States Preventative Services Task Force (USPSTF) has recommendations on which screening measures are effective Screening During History and Physical Exam • Measure height and weight (for BMI/obesity) • Measure blood pressure (for hypertension) • Assess for tobacco, alcohol, and drug use • Detailed sexual history, including risk factors for STDs Screening Tests • Papanicolaou test every 3 years starting at age 21, stopping age 65 • Chlamydia for sexually active women under age of 25 • Routine HIV screening for ages 13 to 64 • Biennial mammograms for women age 50 to 74 • Cholesterol screening (Total and HDL) every 5 years in men >35 years and women >45 years • Fasting glucose if sustained blood pressure >135/80 mmHg • Colonoscopy every 10 years above age of 50 until age 74; may also have occult blood testing yearly or flexible sigmoidoscopy every 5 years • Abdominal aortic aneurysm for male adults between 65 to 75, if history of smoking present • Osteoporosis (via BMD) in women >65, or 60 to 64 if body weight below 70 kg Family History Taking a Family History • Screen for diseases that family members have • Inquire specifically about early onset cardiovascular disease and 1st and 2nd degree relatives with cancer (and what type/age of onset) Genetic Testing • More useful for high risk populations, or if suspected • Testing should aid in diagnosis and/or management ° BRCA or FAP mutation may lead to aggressive screening and interventions 2 INTERNAL MEDICINE IN-REVIEW l INREVIEWIM.COM © 2013 Educational Testing & Assessment Systems. All Rights Reserved. This document contains proprietary information, images, and marks of Educational Testing & Assessment Systems. No reproduction or use of any portion of the contents of these materials may be made without the express written consent of Educational Testing & Assessment Systems. If you feel you have obtained this illegally, please contact Educational Testing & Assessment Systems immediately. Immunizations Table 1.1: Immunizations Vaccine Frequency Indications (blank indicates universal) Hepatitis A 2 doses once • Men who have sex with men • Injection drug users • Occupational (food handlers) • Travel to endemic areas • Chronic liver disease Hepatitis B 3 doses • Sexually active young adults • Healthcare or public safety workers • Travel Human papillomavirus vaccine Females 19-26 years, males 19-21 years, consider 22-26 – 3 doses Influenza Annually Measles-Mumps-Rubella Should have as a child May have to check serologies if unsure of history; adults born before 1957 considered immune Meningococcal vaccine 1 dose • 1st year college students • HIV or asplenia Pneumococcal vaccine 1 or 2 doses • Age >65 • Chronic lung disease, diabetes, chronic liver disease, asplenia Tetanus-Diphtheria-Acellular Every 10 years • Tdap booster once, followed Pertussis (Td or Tdap) by Td every 10 years Varicella 2 doses Zoster 1 dose Age 60 and above Lifestyle Risk Factors Behavioral Counseling • Brief interventions at office visits can be effective • Use the 5 “A”s: Assess, Advise, Agree, Assist, Arrange Physical Inactivity • Should encourage 30 minutes of aerobic exercise 5 times weekly • Strengthening exercise at least twice weekly • Medical screening not needed in asymptomatic patients • Encourage activity to reduce sedentary behavior for those with chronic disease or in ages >65 years Substance Use Disorders • Tobacco ° Assess at each visit ° Brief counseling and possibly medication • Routinely screen for alcohol misuse and abuse—most frequently in young adults and smokers ° Can use CAGE questionnaire GENERAL INTERNAL MEDICINE 3 © 2013 Educational Testing & Assessment Systems. All Rights Reserved. This document contains proprietary information, images, and marks of Educational Testing & Assessment Systems. No reproduction or use of any portion of the contents of these materials may be made without the express written consent of Educational Testing & Assessment Systems. If you feel you have obtained this illegally, please contact Educational Testing & Assessment Systems immediately. ° If at-risk—brief counseling ° If dependence—referral to treatment • Illicit drugs: Look for behavior changes, legal troubles, and medical sequelae ° Referral or brief counseling Sexual Behavior • History oriented to high risk practices (men who have sex with men, multiple partners, contact with sex workers) • Counsel of safe sex practices (use of barrier protection vs. birth control for prevention of STDs) • Offer screening for STDs as appropriate Domestic Violence • Screen if suspected • Intervene if possible; assessing for safety, clear documentation of injuries, and providing resources 1.2 GERIATRIC MEDICINE Functional Assessment • Hearing loss screening ° Patient reported ° Test by whispering in ear while using distraction in other ear • Screen for vision loss • Screen for depression • Probe for deficits in activities of daily living • Inquire for falls ° “Get up and go” good for screening ° To reduce risk of falls: • Monitor meds, stop centrally acting ones • Muscle
Load more

Recommended publications
  • Granuloma De Las Piscinas Carcinoma Basocelular Localmente Avanzado
    Penfigoide gestacional pustuloso Granuloma facial de localización atípica Programa de Educación Médica Continua Variantes de Archivos Argentinos de Dermatología clínicas inusuales de Año 2019, volumen 5, número 4 sarcoidosis Octubre, Noviembre y Diciembre 2019. cutánea Precio: $200 Carcinoma basocelular localmente avanzado tratado con Vismodegib Granuloma de las piscinas www.archivosdermato.org.ar [email protected] Educando Nos Programa de Educación Médica Continua de Archivos Argentinos de Dermatología Año 2019, volumen 5, número 4 Sumario Octubre, Noviembre y Diciembre 2019 Editorial Acrodermatitis enteropática 3 Glorio Roberto 36 Ruiz Díaz María, Kuen Bernardita, Caggia Antonella, Díaz Ysabel, Lozinsky Liliana 4 Reglamento de publicaciones Jornadas de Educación 40 Médica Continua Granuloma facial de 6 localización atípica Carcinoma basocelular Digilio Marianela, Manzano Roxana, Bendjuia Gabriela, 42 localmente avanzado tratado Schroh Roberto, Feinsilber Daniel con Vismodegib Van Caester Leandro Rodolfo, Alfaro María Florencia, Consigli Javier, De La Colina Marcelo, Manrique Valeria, Variantes clínicas inusuales de Pereyra Susana Beatriz 10 sarcoidosis cutánea Espósito Daniela, Márquez, Juan Manuel, López Di Noto Ada Laura, Marcucci Carolina, Sánchez Graciela, Merola Gladys Seguimiento en pacientes 46 sensibilizados a Queratosis folicular invertida de metilisotiazolinona 18 localización infrecuente Russo Juan Pedro, Palazzolo Juan Francisco, Adorni Romina, Consigli Carlos Landau Débora, Caruso Territoriale Antonella, Valente
    [Show full text]
  • Tonsillopharyngitis - Acute (1 of 10)
    Tonsillopharyngitis - Acute (1 of 10) 1 Patient presents w/ sore throat 2 EVALUATION Yes EXPERT Are there signs of REFERRAL complication? No 3 4 EVALUATION Is Group A Beta-hemolytic Yes DIAGNOSIS Streptococcus (GABHS) • Rapid antigen detection test infection suspected? (RADT) • roat culture No TREATMENT EVALUATION No A Supportive management Is GABHS confi rmed? B Pharmacological therapy (Non-GABHS) Yes 5 TREATMENT A EVALUATE RESPONSEMIMS Supportive management TO THERAPY C Pharmacological therapy • Antibiotics Poor/No Good D Surgery, if recurrent or complicated response response REASSESS PATIENT COMPLETE THERAPY & REVIEW THE DIAGNOSIS© Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B269 © MIMS Pediatrics 2020 Tonsillopharyngitis - Acute (2 of 10) 1 ACUTE TONSILLOPHARYNGITIS • Infl ammation of the tonsils & pharynx • Etiologies include bacterial (group A β-hemolytic streptococcus, Haemophilus infl uenzae, Fusobacterium sp, etc) & viral (infl uenza, adenovirus, coronavirus, rhinovirus, etc) pathogens • Sore throat is the most common presenting symptom in older children TONSILLOPHARYNGITIS 2 EVALUATION FOR COMPLICATIONS • Patients w/ sore throat may have deep neck infections including epiglottitis, peritonsillar or retropharyngeal abscess • Examine for signs of upper airway obstruction Signs & Symptoms of Sore roat w/ Complications • Trismus • Inability to swallow liquids • Increased salivation or drooling • Peritonsillar edema • Deviation of uvula
    [Show full text]
  • Unit 3 Bites and Stings
    First Aid in Common and Environmental Emergencies UNIT 3 BITES AND STINGS Structure 3.0 Introduction 3.1 Objectives 3.2 Bites and Stings 3.2.1 Definition, Causes, Types and Recognition of Bites and Stings 3.2.2 Assessment of the Victim and General First Aid 3.3 Various Bites/Stings 3.3.1 Scorpion Bite and Spider Bite 3.3.2 Snake Bite 3.3.3 Insect Bite 3.3.4 Animal Bites (Dog Bite/Monkey Bites) 3.3.5 Human Bites 3.4 Let Us Sum Up 3.5 Keywords 3.6 Answers to Check Your Progress 3.7 References and Further Readings 3.0 INTRODUCTION Bites and stings are commonly seen in the rural and remote areas. Nowadays, however, they can occur in urban areas also. Lakhs of people every year are bitten or stung by someone or something. These emergencies include bites and stings due to various reasons. These bites or stings need to be identified and treated early as they affect some part or the whole of the body which can cause mild, moderate or severe reaction and can even be life-threatening. Most are not medical emergencies but however, treatment is usually required if there is bleeding, wounds or infection. All bites and stings are not same. Different First Aid treatment and care is needed depending on the type of insect or animal that has caused the bite. Some species are more dangerous and cause more harm compared to others. Hence, in this unit we shall discuss the different types of bites and stings, causes, recognition and first aid in these situations.
    [Show full text]
  • Summary of Reported Animal Bites, 2019 Allegheny County, PA
    Summary of Reported Animal Bites, 2019 Allegheny County, PA Prepared by S. Grace Hutko, BS Graduate School of Public Health University of Pittsburgh Kristen Mertz, MD, MPH Infectious Disease Epidemiology Program Allegheny County Health Department L. Renee Miller, BS, BSN, RN Immunization Program Allegheny County Health Department February 2021 Introduction Rabies, a viral zoonotic disease that is nearly always fatal, is a significant global public health concern.1 Worldwide, rabies causes tens of thousands of deaths every year, with dog bites responsible for 99% of human cases.2 In the United States, however, most rabies is found in wild animals, such as bats and raccoons, and there are only one or two human cases per year. In Pennsylvania, there have not been any cases of human rabies since 1984.1 The low incidence of human rabies in the US is attributed to a robust public health surveillance and testing system, widespread availability of post-exposure prophylaxis (PEP), and rabies vaccination for pets.3 In Pennsylvania, all healthcare providers are required by law to report animal bites.4 In the event a domestic animal bites a human, the animal is placed on in-home quarantine, usually for a period of ten days, and monitored for signs of rabies. If the animal is already deceased, the owner is asked to submit the animal for testing. If the animal is unavailable for observation or testing, or tests positive for rabies, the victim is directed to seek medical care to receive PEP. PEP includes rabies immune globulin given on day 0 and rabies vaccine given on days 0, 3, 7, and 14 after being evaluated by a healthcare provider.
    [Show full text]
  • 15. Dermatology Eponyms
    Dermatology Eponyms DERMATOLOGY EPONYMS – PHENOMEN / SIGN – LEXICON (D) Brzeziński Piotr1, Wollina Uwe2, Poklękowska Katarzyna3, Khamesipour Ali4, Herrero Gonzalez Jose Eugenio5, Bimbi Cesar6, Di Lernia Vito7, Karwan Krzysztof 8 16th Military Support Unit, Ustka, Poland. [email protected] 2Department of Dermatology & Allergology, Hospital Dresden-Friedrichstadt, Academic Teaching Hospital of the Technical University of Dresden, Dresden, Germany [email protected] 3Mazowiecki Branch of the National Health Fund, Warsaw, Poland [email protected] 4Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran [email protected] 5Malalties Ampul.lars i Porfíries, Departament de Dermatologia, Hospital del Mar, Barcelona, Spain [email protected] 6Brazilian Society of Dermatology [email protected] 7Department of Dermatology, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy [email protected] 8The Emergency Department, Military Institute of Medicine, Warsaw, Poland [email protected] N Dermatol Online. 2011; 2(3): 158-170 Date of submission: 08.04.2011 / acceptance: 29.05.2011 Conflicts of interest: None DANIELSSEN’S SIGN Anesthetic leprosy. A form of leprosy chiefly affecting the nerves, marked by hyperesthesia succeeded by anesthesia, and by paralysis, ulceration, and various trophic disturbances, terminating in gangrene and mutilation. In 1895 I presented to the Ohio State Medical Society two sisters, natives of Ohio, who manifested appearances of anesthetic leprosy. Synonyms: Danielssen disease, Danielssen-Boeck disease, dry leprosy, trophoneurotic leprosy. OBJAW DANIELSSENA Anesthetic leprosy. Postać trądu głównie wpływająca na nerwy, początkowo charakteryzuje się oznaczone przeczulicą, następcą znieczulicą i paraliŜem, owrzodzeniem i róŜnymi zaburzeniami troficznymi, kończąca się w gangreną i okaleczeniem. W 1895 roku przedstawiono w Ohio State Medical Society dwie siostry z Ohio, u których występowały objawy anesthetic Figure 1.
    [Show full text]
  • Pathological Investigation of Rosacea with Particular Regard Of
    CORE Metadata, citation and similar papers at core.ac.uk Provided by White Rose E-theses Online A Clinico-Pathological Investigation of Rosacea with Particular Regard to Systemic Diseases Dr. Mustafa Hassan Marai Submitted in accordance with the requirements for the degree of Doctor of Medicine The University of Leeds School of Medicine May 2015 “I can confirm that the work submitted is my own and that appropriate credit has been given where reference has been made to the work of others” “This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement” May 2015 The University of Leeds Dr. Mustafa Hassan Marai “The right of Dr Mustafa Hassan Marai to be identified as Author of this work has been asserted by him in accordance with the Copyright, Designs and Patents Act 1988” Acknowledgement Firstly, I would like to thank all the patients who participate in my rosacea study, giving their time and providing me with all of the important information about their disease. This is helped me to collect all of my study data which resulted in my important outcome of my study. Secondly, I would like to thank my supervisor Dr Mark Goodfield, consultant Dermatologist, for his continuous support and help through out my research study. His flexibility, understanding and his quick response to my enquiries always helped me to relive my stress and give me more strength to solve the difficulties during my research. Also, I would like to thank Dr Elizabeth Hensor, Data Analyst at Leeds Institute of Molecular Medicine, Section of Musculoskeletal Medicine, University of Leeds for her understanding the purpose of my study and her help in analysing my study data.
    [Show full text]
  • Pathogenesis of Rosacea Anetta E
    REVIEW Pathogenesis of Rosacea Anetta E. Reszko, MD, PhD; Richard D. Granstein, MD Rosacea is a chronic, common skin disorder whose pathogenesis is incompletely understood. An inter- play of multiple factors, including genetic predisposition and environmental, neurogenic, and microbial factors, may be involved in the disease process. Rosacea subtypes, identified in the recently published standard classification system by the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea, may in fact represent different disease processes, and identifying subtypes may allow investigators to pursue more precisely focused studies. New developments in molecular biology and genetics hold promise for elucidating the interplay of the multiple factors involved in the pathogen- esis of rosacea, as well as providing the bases for potential new therapies. osacea is a common, chronic skin disorder and secondary features needed for the clinical diagnosis primarily affecting the central and con- of rosacea. Primary features include flushing (transient vex areas of COSthe face. The nose, cheeks, DERM erythema), persistent erythema, papules and pustules, chin, forehead, and glabella are the most and telangiectasias. Secondary features include burn- frequently affected sites. Less commonly ing and stinging, skin dryness, plaque formation, dry affectedR sites include the infraorbital, submental, and ret- appearance, edema, ocular symptoms, extrafacial mani- roauricular areas, the V-shaped area of the chest, and the festations, and phymatous changes. One or more of the neck, the back, and theDo scalp. Notprimary Copy features is needed for diagnosis.1 The disease has a variety of clinical manifestations, Several authors have theorized that rosacea progresses including flushing, persistent erythema, telangiecta- from one stage to another.2-4 However, recent data, sias, papules, pustules, and tissue and sebaceous gland including data on therapeutic modalities of various sub- hyperplasia.
    [Show full text]
  • Venom Evolution Widespread in Fishes: a Phylogenetic Road Map for the Bioprospecting of Piscine Venoms
    Journal of Heredity 2006:97(3):206–217 ª The American Genetic Association. 2006. All rights reserved. doi:10.1093/jhered/esj034 For permissions, please email: [email protected]. Advance Access publication June 1, 2006 Venom Evolution Widespread in Fishes: A Phylogenetic Road Map for the Bioprospecting of Piscine Venoms WILLIAM LEO SMITH AND WARD C. WHEELER From the Department of Ecology, Evolution, and Environmental Biology, Columbia University, 1200 Amsterdam Avenue, New York, NY 10027 (Leo Smith); Division of Vertebrate Zoology (Ichthyology), American Museum of Natural History, Central Park West at 79th Street, New York, NY 10024-5192 (Leo Smith); and Division of Invertebrate Zoology, American Museum of Natural History, Central Park West at 79th Street, New York, NY 10024-5192 (Wheeler). Address correspondence to W. L. Smith at the address above, or e-mail: [email protected]. Abstract Knowledge of evolutionary relationships or phylogeny allows for effective predictions about the unstudied characteristics of species. These include the presence and biological activity of an organism’s venoms. To date, most venom bioprospecting has focused on snakes, resulting in six stroke and cancer treatment drugs that are nearing U.S. Food and Drug Administration review. Fishes, however, with thousands of venoms, represent an untapped resource of natural products. The first step in- volved in the efficient bioprospecting of these compounds is a phylogeny of venomous fishes. Here, we show the results of such an analysis and provide the first explicit suborder-level phylogeny for spiny-rayed fishes. The results, based on ;1.1 million aligned base pairs, suggest that, in contrast to previous estimates of 200 venomous fishes, .1,200 fishes in 12 clades should be presumed venomous.
    [Show full text]
  • Z:\My Documents\WPDOCS\IACUC
    ZOONOTIC DISEASES OF LABORATORY, AGRICULTURAL, AND WILDLIFE ANIMALS July, 2007 Michael S. Rand, DVM, DACLAM University Animal Care University of Arizona PO Box 245092 Tucson, AZ 85724-5092 (520) 626-6705 E-mail: [email protected] http://www.ahsc.arizona.edu/uac Table of Contents Introduction ............................................................................................................................................. 3 Amebiasis ............................................................................................................................................... 5 B Virus .................................................................................................................................................... 6 Balantidiasis ........................................................................................................................................ 6 Brucellosis ........................................................................................................................................ 6 Campylobacteriosis ................................................................................................................................ 7 Capnocytophagosis ............................................................................................................................ 8 Cat Scratch Disease ............................................................................................................................... 9 Chlamydiosis .....................................................................................................................................
    [Show full text]
  • Richtlijn Acneïforme Dermatosen
    Richtlijn Acneïforme dermatosen Richtlijn: Acneïforme dermatosen Colofon Richtlijn Acneïforme dermatosen © 2010, Nederlandse Vereniging voor Dermatologie en Venereologie (NVDV) Postbus 8552, 3503 RN Utrecht Telefoon: 030-2823180 E-mail: [email protected] Alle rechten voorbehouden. Niets uit deze uitgave mag worden verveelvoudigd of openbaar worden gemaakt, in enige vorm of op enige wijze, zonder voorafgaande schriftelijke toestemming van de Nederlandse Vereniging voor Dermatologie en Venereologie. Deze richtlijn is opgesteld door een daartoe geïnstalleerde werkgroep van de Nederlandse Vereniging voor Dermatologie en Venereologie. De richtlijn is vervolgens vastgesteld in de algemene ledenvergadering. De richtlijn vertegenwoordigt de geldende professionele standaard ten tijde van de opstelling van de richtlijn. De richtlijn bevat aanbevelingen van algemene aard. Het is mogelijk dat deze aanbevelingen in een individueel geval niet van toepassing zijn. De toepasbaarheid en de toepassing van de richtlijnen in de praktijk is de verantwoordelijkheid van de behandelend arts. Er kunnen zich feiten of omstandigheden voordoen waardoor het wenselijk is dat in het belang van de patiënt van de richtlijn wordt afgeweken. 1 Versie 18-06-2010 WERKGROEP Prof. dr. P.C.M. van de Kerkhof, dermatoloog, voorzitter werkgroep Mw. J.A. Boer, huidtherapeut Drs. R.J. Borgonjen, ondersteuner werkgroep Dr .J.J.E. van Everdingen, dermatoloog Mw. M.E.M. Janssen, huidtherapeut Drs. M. Kerzman, NHG/huisarts Dr. J. de Korte, dermatopsycholoog Drs. M.F.E. Leenarts, dermatoloog i.o. Drs. M.M.D. van der Linden, dermatoloog Dr. J.R. Mekkes, dermatoloog Drs. J.E. Mooij, promovendus dermatologie Drs. L. van ’t Oost, dermatoloog i.o. Dr. V. Sigurdsson, dermatoloog Mw. C. Swinkels, hidradenitis patiënten vereniging/patiëntvertegenwoordiger Drs.
    [Show full text]
  • Swedres-Svarm 2019
    2019 SWEDRES|SVARM Sales of antibiotics and occurrence of antibiotic resistance in Sweden 2 SWEDRES |SVARM 2019 A report on Swedish Antibiotic Sales and Resistance in Human Medicine (Swedres) and Swedish Veterinary Antibiotic Resistance Monitoring (Svarm) Published by: Public Health Agency of Sweden and National Veterinary Institute Editors: Olov Aspevall and Vendela Wiener, Public Health Agency of Sweden Oskar Nilsson and Märit Pringle, National Veterinary Institute Addresses: The Public Health Agency of Sweden Solna. SE-171 82 Solna, Sweden Östersund. Box 505, SE-831 26 Östersund, Sweden Phone: +46 (0) 10 205 20 00 Fax: +46 (0) 8 32 83 30 E-mail: [email protected] www.folkhalsomyndigheten.se National Veterinary Institute SE-751 89 Uppsala, Sweden Phone: +46 (0) 18 67 40 00 Fax: +46 (0) 18 30 91 62 E-mail: [email protected] www.sva.se Text, tables and figures may be cited and reprinted only with reference to this report. Images, photographs and illustrations are protected by copyright. Suggested citation: Swedres-Svarm 2019. Sales of antibiotics and occurrence of resistance in Sweden. Solna/Uppsala ISSN1650-6332 ISSN 1650-6332 Article no. 19088 This title and previous Swedres and Svarm reports are available for downloading at www.folkhalsomyndigheten.se/ Scan the QR code to open Swedres-Svarm 2019 as a pdf in publicerat-material/ or at www.sva.se/swedres-svarm/ your mobile device, for reading and sharing. Use the camera in you’re mobile device or download a free Layout: Dsign Grafisk Form, Helen Eriksson AB QR code reader such as i-nigma in the App Store for Apple Print: Taberg Media Group, Taberg 2020 devices or in Google Play.
    [Show full text]
  • Clinical Dermatology Notice
    This page intentionally left blank Clinical Dermatology Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The editors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the editors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of such information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. a LANGE medical book Clinical Dermatology Carol Soutor, MD Clinical Professor Department of Dermatology University of Minnesota Medical School Minneapolis, Minnesota Maria K. Hordinsky, MD Chair and Professor Department of Dermatology University of Minnesota Medical School Minneapolis, Minnesota New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2013 by McGraw-Hill Education, LLC.
    [Show full text]